Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...

Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...

Use of hypoglossal nerve stimulation (HGNS) may be effective for treating obstructive sleep apnea (OSA), but a higher body mass index (BMI) and supine sleeping position may decrease effects, according ...

About a third of American adults are living with obstructive sleep apnea, a condition that robs people of restful sleep and ...

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...

Early treatment of obstructive sleep apnea may decrease the risk of Parkinson's disease, a new study published Monday finds.

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, announces that the U.S. Food and Drug Administration (FDA) has granted ...

HealthDay News — Obstructive sleep apnea (OSA) seems to be an independent risk factor for development of Parkinson disease, and early use of continuous positive airway pressure (CPAP) could modify the ...

Please provide your email address to receive an email when new articles are posted on . In an adjusted model, there was a significant link between long-term PM 10 exposure and apnea-hypopnea index.

New research among older adults with sleep apnea reveals that verbal memory performance is significantly worse in women—but ...

Older women with comorbid insomnia and sleep apnea (COMISA) experienced significantly worse verbal memory performance compared to those with sleep apnea alone, as well as men with COMISA, according to ...